Product Information
BENZONATATE 200 MG CAPSULE is a generic product labeled by TAGI Pharma Inc., priced at $0.1062 per EA under NDC 51224000160. Its NADAC has been published 436 times since Nov 2, 2016.
FDA first approved this application on Jul 31, 2015. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Benzonatate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
TAGI Pharma Inc.NDC
51224000160
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
BENZONATATEApproval Type
Generic (ANDA)
FDA Application
ANDA202765FDA Approved
7/31/2015
TE Code
AA
On Market Since
8/10/2015
Pharmacological Classes
Price Statistics
The NADAC for BENZONATATE 200 MG CAPSULE has been published 436 times since Nov 2, 2016, and over the history we have for it it has declined 69.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1062 per EA |
|---|---|
| All-time high | $0.3557 (Jan 11, 2017) |
| All-time low | $0.0829 (Nov 20, 2024) |
| Median price | $0.1394 |
| Average price | $0.1665 |
| Largest weekly change | -30.2% (Nov 20, 2024) |
| Weeks tracked | 436 |
| Tracking since | Nov 2, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-6.0%
5Y
-21.5%
All
-69.2%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BENZONATATE 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BENZONATATE 200 MG CAPSULE, manufactured by TAGI Pharma Inc., is $0.1062 per EA (NDC 51224000160), effective Mar 5, 2025.
How has the price of BENZONATATE 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BENZONATATE 200 MG CAPSULE has declined 69.2%. It has been tracked across 436 weekly CMS publications since Nov 2, 2016.
What are the highest and lowest recorded NADAC prices for BENZONATATE 200 MG CAPSULE?
Since Nov 2, 2016, the NADAC for BENZONATATE 200 MG CAPSULE has ranged from a low of $0.0829 (Nov 20, 2024) to a high of $0.3557 (Jan 11, 2017), with a median of $0.1394 per EA.
Are there cheaper alternatives to BENZONATATE 200 MG CAPSULE?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BENZONATATE 200 MG CAPSULE, is $0.1021 per EA — about 4% below BENZONATATE 200 MG CAPSULE.
Who manufactures BENZONATATE 200 MG CAPSULE?
BENZONATATE 200 MG CAPSULE (NDC 51224000160) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.